Amélie Lusque
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 11
- Cancer Research top 10%
- Breast Cancer Treatment Studies 8
- Cancer Genomics and Diagnostics 7
-
- Advanced Breast Cancer Therapies 10
- Lung Cancer Treatments and Mutations 7
- Genetics top 10%
- Glioma Diagnosis and Treatment 7
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments 5
-
- Head and Neck Cancer Studies 5
- Co-authors
- Julien MazièresThomas FilleronIsabelle RouquetteAnne PradinesGilles FavreNicolas GuibertJean MourlanetteNadia Boubekeur
- Partner nations
- FranceJapanUnited States
In The Last Decade
Amélie Lusque
56 papers receiving 927 citations
Peers
Comparison fields: 5 of 76
- Oncology 528
- Cancer Research 210
- Pulmonary and Respiratory Medicine 287
- Genetics 90
- Obstetrics and Gynecology 63
Countries citing papers authored by Amélie Lusque
This map shows the geographic impact of Amélie Lusque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélie Lusque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélie Lusque more than expected).
Fields of papers citing papers by Amélie Lusque
This network shows the impact of papers produced by Amélie Lusque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélie Lusque. The network helps show where Amélie Lusque may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amélie Lusque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 8 | |
| 11 | 2020 | 70 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 37 | |
| 14 | 2020 | 10 | |
| 15 | 2020 | 11 | |
| 16 | 2020 | 12 | |
| 17 | 2019 | 96 | |
| 18 | 2019 | 30 | |
| 19 | 2019 | 4 | |
| 20 | 2019 | 33 |
About Amélie Lusque
Amélie Lusque is a scholar working on Otorhinolaryngology, Oncology and Cancer Research, having authored 61 papers that have together received 929 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Advanced Breast Cancer Therapies (10 papers), Breast Cancer Treatment Studies (8 papers), Glioma Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (7 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Head and Neck Cancer Studies (5 papers). The work is most often cited by research in Oncology (528 citations), Cancer Research (210 citations) and Pulmonary and Respiratory Medicine (287 citations). Amélie Lusque has collaborated with scholars based in France, Japan and United States. Frequent co-authors include Julien Mazières, Thomas Filleron, Isabelle Rouquette, Anne Pradines, Gilles Favre, Nicolas Guibert, Jean Mourlanette, Nadia Boubekeur, Myriam Delaunay and Élodie Chantalat. Their work appears in journals such as Nature Communications, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.